SunRun is looking to the public equity markets to extend growth through an IPO targeting as much as US$268.5m in fresh capital. The largely primary offering builds on a recent securitisation that underpins economics of long-term power sales.
Impressive size increases achieved on the IPOs of ProNAi Therapeutics and Chiasma last week were facilitated in part by allowances in the Securities Act of 1933 that provide issuers with flexibility to substantially upsize before hitting maximum thresholds.
Cerberus Capital-backed Albertsons Companies has formalised plans to go public by submitting preliminary documents with the SEC. The grocer becomes the latest in a string of highly leveraged, private equity-backed companies that could go public before year-end.